Author:
Borgquist Signe,Jögi Annika,Pontén Fredrik,Rydén Lisa,Brennan Donal J,Jirström Karin
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Mo H, Elson CE: Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood). 2004, 229: 567-585.
2. Liao JK: Isoprenoids as mediators of the biological effects of statins. J Clin Invest. 2002, 110: 285-288.
3. Wejde J, Blegen H, Larsson O: Requirement for mevalonate in the control of proliferation of human breast cancer cells. Anticancer Res. 1992, 12: 317-324.
4. Sivaprasad U, Abbas T, Dutta A: Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Mol Cancer Ther. 2006, 5: 2310-2316. 10.1158/1535-7163.MCT-06-0175.
5. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC: Breast cancer growth prevention by statins. Cancer Res. 2006, 66: 8707-8714. 10.1158/0008-5472.CAN-05-4061.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献